Your browser doesn't support javascript.
loading
DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020.
Jedlowski, Patrick M; Jedlowski, Mahdieh F; Fazel, Maryam T.
  • Jedlowski PM; Division of Dermatology, University of Arizona College of Medicine - Tucson, 7165 N Pima Canyon Dr, Tucson, AZ, 85718, USA. pjedlowski@email.arizona.edu.
  • Jedlowski MF; Division of Dermatology, University of Arizona College of Medicine - Tucson, 7165 N Pima Canyon Dr, Tucson, AZ, 85718, USA.
  • Fazel MT; Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, Tucson, AZ, USA.
Am J Clin Dermatol ; 22(6): 891-900, 2021 Nov.
Article en En | MEDLINE | ID: mdl-34287770
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: United States Food and Drug Administration / Penfigoide Ampolloso / Sistemas de Registro de Reacción Adversa a Medicamentos / Diabetes Mellitus / Inhibidores de la Dipeptidil-Peptidasa IV Límite: Humans País como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: United States Food and Drug Administration / Penfigoide Ampolloso / Sistemas de Registro de Reacción Adversa a Medicamentos / Diabetes Mellitus / Inhibidores de la Dipeptidil-Peptidasa IV Límite: Humans País como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article